Literature DB >> 7160370

Evaluation of the Micur microdilution systems for antibiotic susceptibility testing of gram-negative and gram-positive bacteria.

F Kayser, K Machka, L Wieczorek, D Banauch, W Bablok, I Braveny.   

Abstract

Two commercial systems for testing the antimicrobial susceptibility of bacteria were evaluated in a collaborative study at two sites using 306 freshly isolated clinical strains. Gram-negative bacteria were tested with the Micur RST 02 and gram-positive bacteria with the Micur RST 03, systems for MIC titration. For categorization of bacterial susceptibility into sensitive, intermediate or resistant, the Micur ST 02 and 03 were used for gram-negative and gram-positive bacteria respectively. The broth microdilution technique served as reference method. A total of 3672 MIC pairs were determined. MICs obtained with the Micur RST 02/03 were found to be 96.9% in agreement (+/- one log2 dilution) with the reference method results. The inter-laboratory and intra-laboratory reproducibility for the Micur RST tested with four ATCC reference strains was 97.5% and 98.5% respectively. Categorization of bacterial susceptibility with the Micur ST 02/03 agreed with 94.9% of the Micur RST results and 91.6% of the reference method results. On account of their accuracy, reproducibility and long shelf-life the Micur RST and ST systems offer a convenient method for testing antimicrobial susceptibility of bacteria in the clinical microbiology laboratory.

Mesh:

Substances:

Year:  1982        PMID: 7160370     DOI: 10.1007/bf02019935

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  6 in total

1.  Infectious diseases 1979--antimicrobial susceptibility tests.

Authors:  J A Washington
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

2.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

3.  [Problems in the determination of susceptibility of bacteria using the agar diffusion test. Correlation statistics and construction of a decisive procedure].

Authors:  H Kaufmann; H Neussel; G Linzenmeier
Journal:  Arzneimittelforschung       Date:  1973-06

4.  Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: a collaborative investigation.

Authors:  R N Jones; C Thornsberry; A L Barry; T L Gavan
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

5.  Evaluation of the MICUR system for quantitative antimicrobial susceptibility testing: a multiphasic comparison with reference methods.

Authors:  R N Jones; A L Barry; J Bigelow; T L Gavan; C Thornsberry
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

6.  Evaluation of the sensititre microdilution antibiotic susceptibility system against recent clinical isolates: three-laboratory collaborative study.

Authors:  R N Jones; T L Gavan; A L Barry
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

  6 in total
  7 in total

1.  Comparison of the serum bactericidal activity of ceftriaxone/piperacillin and ceftriaxone/netilmicin.

Authors:  K Machka; M Röbl; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

2.  Bactericidal activity of imipenem in serum.

Authors:  K Machka
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

3.  Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.

Authors:  K Machka; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

4.  Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.

Authors:  K Machka; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

5.  Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.

Authors:  K Machka; D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

6.  Comparative in vitro activity of cefetamet (RO 15-8074).

Authors:  K Machka; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

7.  In vitro activity of HR 810, a new broad-spectrum cephalosporin.

Authors:  K Machka; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.